ReviewStem cell research & therapy2024

Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells.

Zahra Molaei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.